Insider buying, week of October 26, 2026

This article summarizes the supplied SEC Form 4 facts for purchases dated October 26 and 28, 2026. It reports transaction amounts, roles, holding changes, company-level counts of insiders buying within 14 days, and the associated scores; it does not interpret those scores.

Largest purchases

The largest listed purchase was by Healy James, a director of Rapport Therapeutics (RAPP): $20.00 million on October 28, with a 51% holding change, seven insiders buying within 14 days, and a score of 81. The same filing facts also list three other purchases by Healy on October 28: $134,000 (55% holding change; score 69), $146,000 (38%; score 64), and $79,000 (34%; score 62). Each is reported with seven insiders buying within 14 days.

Other purchases of at least $500,000 were:

ScoreTickerCompanyInsiderRoleTrade dateValueHolding +Cluster
81RAPPRapport Therapeutics, Inc.Healy JamesDirector2026-10-28$20.00M51%7 insiders
69RAPPRapport Therapeutics, Inc.Healy JamesDirector2026-10-28$134K55%7 insiders
68STCSTEWART INFORMATION SERVICES CORPEppinger Frederick HCEO2026-10-26$133K2%5 insiders
68NPBNORTHPOINTE BANCSHARES INCWilliams Charles Alan / Charles A Williams Tr Charles A Williams TrustCEO2026-10-26$766K2%4 insiders
67ACNAccenture plcSweet Julie SpellmanCEO2026-10-26$2.49M26%2 insiders
64RAPPRapport Therapeutics, Inc.Healy JamesDirector2026-10-28$146K38%7 insiders
64TFCTRUIST FINANCIAL CORPLyons Michael P.CEO2026-10-28$1.21M119%
62RAPPRapport Therapeutics, Inc.Healy JamesDirector2026-10-28$79K34%7 insiders
61BBTBeacon Financial CorpPolito KarynDirector2026-10-26$31Knew6 insiders
58BBTBeacon Financial CorpCallahan Mary AnneDirector2026-10-28$97K18%6 insiders
58TTMITTM TECHNOLOGIES INCRoks EdwinCEO2026-10-28$440K8%2 insiders
58ACNAccenture plcSweet Julie SpellmanCEO2026-10-26$515K6%2 insiders

Source: SEC Form 4 filings. Score is a data signal, not a recommendation. Not investment advice.